|Bid||52.96 x 3200|
|Ask||53.19 x 900|
|Day's Range||51.81 - 54.12|
|52 Week Range||7.50 - 65.43|
|Beta (5Y Monthly)||1.68|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
The FDA accepts ChemoCentryx's (CCXI) NDA for avacopan, for the treatment of ANCA-associated vasculitis.
ChemoCentryx, Inc. (NASDAQ:CCXI) shareholders might be concerned after seeing the share price drop 20% in the last...